BridgeMD
Compares treatment options for Tendinopathy of Rotator Cuff
Official title Corticosteroid Versus PRP Injections for Shoulder Tendinopathy
ClinicalTrials.gov ID: NCT07094178
What this study is testing
- What it's testing
- Shoulder tendinopathy is a common condition that causes shoulder pain and limits daily activities. It often results from damage or overuse of the rotator cuff tendons.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years and older
- Diagnosed with simple tendinopathy of the shoulder confirmed by clinical examination and imaging
- Experiencing shoulder pain for at least 4 weeks
- Able to provide informed consent
You likely can't join if
- Previous shoulder surgery on the affected side
- Presence of rotator cuff tear or severe shoulder pathology
- Systemic inflammatory diseases (e.g., rheumatoid arthritis)
- Recent corticosteroid injection in the affected shoulder (within last 3 months)
- Contraindications to corticosteroids or PRP treatment
- Pregnancy or breastfeeding
The study team makes the final eligibility decision.
Where it's taking place
- Tunis, Tunisia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tunis, Tunisia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.